Genomma Lab Internacional SAB de CV (GEKA) Income Statement
Genomma Lab Internacional SAB de CV Income Statement
Last quarter (Q3 2026), Genomma Lab Internacional SAB de CV's total revenue was $4.50B, an increase of 1.26% from the same quarter last year. In Q3, Genomma Lab Internacional SAB de CV's net income was $514.90M. See Genomma Lab Internacional SAB de CV’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 17.54B | $ 18.61B | $ 16.47B | $ 16.82B | $ 15.49B | |
| $ 11.02B | $ 11.93B | $ 10.08B | $ 10.16B | $ 9.56B | |
| $ 7.26B | $ 8.01B | $ 6.82B | $ 6.92B | $ 6.57B | |
| Depreciation and Amortization | $ 379.14M | $ 359.59M | $ 227.30M | $ 227.13M | $ 170.27M |
| $ 3.61B | $ 4.14B | $ 2.78B | $ 3.01B | $ 2.84B | |
| $ 3.76B | $ 3.92B | $ 3.26B | $ 3.25B | $ 3.05B | |
| $ -1.33B | $ -1.03B | $ -1.54B | $ -988.36M | $ -824.67M | |
| $ 2.43B | $ 2.89B | $ 1.72B | $ 2.26B | $ 2.22B | |
| $ 1.61B | $ 1.49B | $ 1.08B | $ 1.39B | $ 1.31B | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.65 | $ 1.53 | $ 1.13 | $ 1.40 | $ 1.30 |
| Diluted EPS | $ 1.65 | $ 1.53 | $ 1.13 | $ 1.40 | $ 1.30 |
| Weighted Average Shares Outstanding | 973.79M | 978.43M | 957.34M | 993.23M | 1.01B |
| Weighted Average Shares Outstanding (Diluted) | 973.79M | 978.43M | 957.34M | 993.23M | 1.01B |
Currency in MXN